Skip to main content
Erschienen in: Rheumatology International 9/2021

05.02.2021 | Genes and Disease

A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls

verfasst von: Burak Ince, Sevil Kamali, Murat Bektaş, Yeliz Duvarci Ögret, Fatma Oğuz Savran, Yasemin Yalçinkaya, Bahar Artim-Esen, Murat Inanç, Lale Öcal, Ahmet Gül

Erschienen in: Rheumatology International | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

We aimed to analyse the distribution of HLA Class 2 genotypes which were reported among the genetic risk factors for ANCA-associated vasculitis (AAV) among Turkish patients in comparison with healthy subjects and previously reported data of AAV cohorts. Ninety-eight patients (F/M: 47/51 and mean age: 49 ± 1.14) were enrolled in the study and records of gender and birthplace-matched 196 healthy kidney donors were used as the control group. Patients were classified according to the clinical subgroups and ANCA serotypes (MPO-AAV, PR3-AAV). DNA was isolated from venous blood from all patients, and high-resolution HLA Class 2 genotyping was carried out by using NGS-Omixon Holotype HLA Kit. The frequencies of HLA-DQB1*03:03, - *06:04, and -DPB1*13:01, -*16:01 and -*66:01:00 alleles were significantly higher, and the frequencies of HLA-DQB1*02:02, -DPB1*02:01 and -*04:01 alleles were lower in the PR3-AAV subgroup (n = 53) compared to the controls. Comparison of amino acid sequences of the associated HLA-DPB1 alleles revealed the sequence of D-E-A-V in risk alleles replaced with the G-G-P-M sequence in protective alleles between 84 and 87th positions. Structural analysis of the HLA-DPB1*02:01 showed that this shared position is in the contact area between HLA-DP α and β chains and within pocket 1 of the antigen-binding groove. First HLA genotyping analysis in Turkish AAV patients revealed a negative correlation between PR3-ANCA positivity and certain HLA-DPB1 alleles contradictory to the results reported from European cohorts. Known functional effects of D-E-A-V sequence on HLA-DPB1 support the importance of our finding, but further studies are needed to reveal its pathogenic mechanisms.
Literatur
1.
Zurück zum Zitat Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suarez LF (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30(Suppl 1):i14-22CrossRef Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suarez LF (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30(Suppl 1):i14-22CrossRef
2.
Zurück zum Zitat Watts RA, Lane SE, Bentham G, Scott DG (2000) Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 43(2):414–419CrossRef Watts RA, Lane SE, Bentham G, Scott DG (2000) Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 43(2):414–419CrossRef
3.
Zurück zum Zitat Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11CrossRef Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11CrossRef
4.
Zurück zum Zitat Nakazawa D, Masuda S, Tomaru U, Ishizu A (2019) Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat Rev Rheumatol 15(2):91–101CrossRef Nakazawa D, Masuda S, Tomaru U, Ishizu A (2019) Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat Rev Rheumatol 15(2):91–101CrossRef
5.
Zurück zum Zitat Schonermarck U, Lamprecht P, Csernok E, Gross WL (2001) Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 40(2):178–184CrossRef Schonermarck U, Lamprecht P, Csernok E, Gross WL (2001) Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 40(2):178–184CrossRef
6.
Zurück zum Zitat Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR et al (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367(3):214–223CrossRef Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR et al (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367(3):214–223CrossRef
7.
Zurück zum Zitat Merkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J et al (2017) Identification of functional and expression polymorphisms associated with risk for antineutrophil cytoplasmic autoantibody-associated vasculitis. Arthritis Rheumatol 69(5):1054–1066CrossRef Merkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J et al (2017) Identification of functional and expression polymorphisms associated with risk for antineutrophil cytoplasmic autoantibody-associated vasculitis. Arthritis Rheumatol 69(5):1054–1066CrossRef
8.
Zurück zum Zitat Shiina T, Inoko H, Kulski JK (2004) An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64(6):631–649CrossRef Shiina T, Inoko H, Kulski JK (2004) An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64(6):631–649CrossRef
9.
Zurück zum Zitat Yang R, Cui Z, Zhao J, Zhao MH (2009) The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease. Clin Immunol 133(2):245–250CrossRef Yang R, Cui Z, Zhao J, Zhao MH (2009) The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease. Clin Immunol 133(2):245–250CrossRef
10.
Zurück zum Zitat Ettinger RA, Papadopoulos GK, Moustakas AK, Nepom GT, Kwok WW (2006) Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles. J Immunol 176(3):1988–1998CrossRef Ettinger RA, Papadopoulos GK, Moustakas AK, Nepom GT, Kwok WW (2006) Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles. J Immunol 176(3):1988–1998CrossRef
11.
Zurück zum Zitat Tsuchiya N (2013) Genetics of ANCA-associated vasculitis in Japan: a role for HLA-DRB1*09:01 haplotype. Clin Exp Nephrol 17(5):628–630CrossRef Tsuchiya N (2013) Genetics of ANCA-associated vasculitis in Japan: a role for HLA-DRB1*09:01 haplotype. Clin Exp Nephrol 17(5):628–630CrossRef
12.
Zurück zum Zitat Xie G, Roshandel D, Sherva R, Monach PA, Lu EY, Kung T et al (2013) Association of granulomatosis with polyangiitis (Wegener’s) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum 65(9):2457–2468CrossRef Xie G, Roshandel D, Sherva R, Monach PA, Lu EY, Kung T et al (2013) Association of granulomatosis with polyangiitis (Wegener’s) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum 65(9):2457–2468CrossRef
13.
Zurück zum Zitat Kilinc MO, Ninis VN, Dagli E, Demirkol M, Ozkinay F, Arikan Z et al (2002) Highest heterogeneity for cystic fibrosis: 36 mutations account for 75% of all CF chromosomes in Turkish patients. Am J Med Genet 113(3):250–257CrossRef Kilinc MO, Ninis VN, Dagli E, Demirkol M, Ozkinay F, Arikan Z et al (2002) Highest heterogeneity for cystic fibrosis: 36 mutations account for 75% of all CF chromosomes in Turkish patients. Am J Med Genet 113(3):250–257CrossRef
14.
Zurück zum Zitat Tuzmen S, Tadmouri GO, Ozer A, Baig SM, Ozcelik H, Basaran S et al (1996) Prenatal diagnosis of beta-thalassaemia and sickle cell anaemia in Turkey. Prenat Diagn 16(3):252–258CrossRef Tuzmen S, Tadmouri GO, Ozer A, Baig SM, Ozcelik H, Basaran S et al (1996) Prenatal diagnosis of beta-thalassaemia and sickle cell anaemia in Turkey. Prenat Diagn 16(3):252–258CrossRef
15.
Zurück zum Zitat Nilsen AT, Karlsen C, Bakland G, Watts R, Luqmani R, Koldingsnes W (2019) Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway. Rheumatology (Oxford) 59(9):2316–2324CrossRef Nilsen AT, Karlsen C, Bakland G, Watts R, Luqmani R, Koldingsnes W (2019) Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway. Rheumatology (Oxford) 59(9):2316–2324CrossRef
16.
Zurück zum Zitat Hilhorst M, Arndt F, Joseph Kemna M, Wieczorek S, Donner Y, Wilde B et al (2016) HLA-DPB1 as a risk factor for relapse in antineutrophil cytoplasmic antibody-associated vasculitis: a cohort study. Arthritis Rheumatol 68(7):1721–1730CrossRef Hilhorst M, Arndt F, Joseph Kemna M, Wieczorek S, Donner Y, Wilde B et al (2016) HLA-DPB1 as a risk factor for relapse in antineutrophil cytoplasmic antibody-associated vasculitis: a cohort study. Arthritis Rheumatol 68(7):1721–1730CrossRef
17.
Zurück zum Zitat Gregersen JW, Erikstrup C, Ivarsen P, Glerup R, Krarup E, Keller KK et al (2019) PR3-ANCA-associated vasculitis is associated with a specific motif in the peptide-binding cleft of HLA-DP molecules. Rheumatology (Oxford) 58(11):1942–1949CrossRef Gregersen JW, Erikstrup C, Ivarsen P, Glerup R, Krarup E, Keller KK et al (2019) PR3-ANCA-associated vasculitis is associated with a specific motif in the peptide-binding cleft of HLA-DP molecules. Rheumatology (Oxford) 58(11):1942–1949CrossRef
18.
Zurück zum Zitat Al-Daccak R, Wang FQ, Theophille D, Lethielleux P, Colombani J, Loiseau P (1991) Gene polymorphism of HLA-DPB1 and DPA1 loci in caucasoid population: frequencies and DPB1-DPA1 associations. Hum Immunol 31(4):277–285CrossRef Al-Daccak R, Wang FQ, Theophille D, Lethielleux P, Colombani J, Loiseau P (1991) Gene polymorphism of HLA-DPB1 and DPA1 loci in caucasoid population: frequencies and DPB1-DPA1 associations. Hum Immunol 31(4):277–285CrossRef
19.
Zurück zum Zitat Diaz G, Amicosante M, Jaraquemada D, Butler RH, Guillen MV, Sanchez M et al (2003) Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84–87 in T cell allorecognition and peptide binding. Int Immunol 15(5):565–576CrossRef Diaz G, Amicosante M, Jaraquemada D, Butler RH, Guillen MV, Sanchez M et al (2003) Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84–87 in T cell allorecognition and peptide binding. Int Immunol 15(5):565–576CrossRef
20.
Zurück zum Zitat Zhang J, Zhan W, Yang B, Tian A, Chen L, Liao Y et al (2017) Genetic polymorphisms of rs3077 and rs9277535 in HLA-DP associated with systemic lupus erythematosus in a Chinese population. Sci Rep 7:39757CrossRef Zhang J, Zhan W, Yang B, Tian A, Chen L, Liao Y et al (2017) Genetic polymorphisms of rs3077 and rs9277535 in HLA-DP associated with systemic lupus erythematosus in a Chinese population. Sci Rep 7:39757CrossRef
21.
Zurück zum Zitat Huang Z, Niu Q, Yang B, Zhang J, Yang M, Xu H et al (2018) Genetic polymorphism of rs9277535 in HLA-DP associated with rheumatoid arthritis and anti-CCP production in a Chinese population. Clin Rheumatol 37(7):1799–1805CrossRef Huang Z, Niu Q, Yang B, Zhang J, Yang M, Xu H et al (2018) Genetic polymorphism of rs9277535 in HLA-DP associated with rheumatoid arthritis and anti-CCP production in a Chinese population. Clin Rheumatol 37(7):1799–1805CrossRef
Metadaten
Titel
A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls
verfasst von
Burak Ince
Sevil Kamali
Murat Bektaş
Yeliz Duvarci Ögret
Fatma Oğuz Savran
Yasemin Yalçinkaya
Bahar Artim-Esen
Murat Inanç
Lale Öcal
Ahmet Gül
Publikationsdatum
05.02.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 9/2021
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-021-04789-4

Weitere Artikel der Ausgabe 9/2021

Rheumatology International 9/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.